Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 10
Submit an article Journal homepage
457
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Alemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal schedule

Tamar TadmorHematology Unit, Bnai-Zion Medical Center, Haifa, IsraelCorrespondence[email protected]
Pages 1831-1833 | Published online: 23 May 2011
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Potential conflict of interest:

A disclosure form provided by the author is available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.